Event Brief
Long-Acting HIV Drug Launched in Zimbabwe
Filed: Feb 22, 2026 at 1:03 AM ET
Summary: Zimbabwe introduces lenacapavir, a biannual HIV prevention drug for high-risk individuals.
WHO: Zimbabwean health authorities
WHAT: Rollout of lenacapavir, an HIV prevention drug
WHEN: Feb 21, 2026 at 11:45 PM ET
WHERE: Zimbabwe
WHY: To provide long-term HIV prevention for those at highest risk
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →